Quarterly Results

ASPIRA PATHLAB & DIAGNOSTICS LTD.

NSE : NABSE : 540788ISIN CODE : INE500C01017Industry : Hospital & Healthcare ServicesHouse : Private
BSE30.800.16 (+0.52 %)
PREV CLOSE ( ) 30.64
OPEN PRICE ( ) 30.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 380
TODAY'S LOW / HIGH ( )30.80 30.82
52 WK LOW / HIGH ( ) 22.7649.5
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
Audited
UnAudited
Audited
Net Sales
34.62
33.21
26.04
34.08
Total Expenditure
38.34
36.9
29.3
32.67
PBIDT (Excl OI)
-3.72
-3.69
-3.26
1.41
Other Income
1
1.44
1
0.73
Operating Profit
-2.72
-2.24
-2.26
2.14
Interest
0.89
0.97
0.98
0.96
Exceptional Items
NA
NA
NA
NA
PBDT
-3.61
-3.21
-3.24
1.18
Depreciation
3.81
3.9
3.92
3.78
Profit Before Tax
-7.42
-7.11
-7.16
-2.6
Tax
NA
NA
NA
NA
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-7.42
-7.11
-7.16
-2.6
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
-7.42
-7.11
-7.16
-2.6
Equity Capital
102.93
102.93
102.93
102.93
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
-0.72
-0.69
-0.69
-0.25
Calculated EPS (Annualised)
-2.88
-2.76
-2.78
-1.01
No of Public Share Holdings
8347736
8347736
8299627
8288971
% of Public Share Holdings
81.1
81.1
80.63
80.53
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-10.74
-11.11
-12.51
4.13
PBIDTM%
-7.85
-6.74
-8.67
6.27
PBDTM%
-10.42
-9.66
-12.44
3.46
PBTM%
-21.43
-21.40
-27.49
-7.62
PATM%
-21.43
-21.40
-27.49
-7.62
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.